Patient-reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real life

Allergy. 2023 Apr;78(4):1113-1116. doi: 10.1111/all.15550. Epub 2022 Oct 21.

Farah Bahbah¹, Catherine Gentil², Bernardo Sousa-Pinto^{3

4}, G Walter Canonica^{5

6}, Philippe Devillier⁷, Oliver Pfaar⁸, Jean Bousquet^{9

10

11}

¹ Stallergenes Greer Ltd, Antony, France.
² Axiodis, Toulouse, France.
³ Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal.
⁴ CINTESIS@RISE - Health Research Network, University of Porto, Porto, Portugal.
⁵ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
⁶ Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
⁷ VIM Suresnes, UMR_0892, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
⁸ Section of Rhinology and Allergy, Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
⁹ Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Berlin, Germany.
¹⁰ Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany.
¹¹ University Hospital Montpellier, Montpellier, France.

No abstract available

Publication types